3D Structure and Function of Neuronal Nicotinic Acetylcholine Receptors
神经元烟碱乙酰胆碱受体的 3D 结构和功能
基本信息
- 批准号:8708228
- 负责人:
- 金额:$ 24.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseBasic ScienceBindingBiochemicalBiological AssayBiophysical ProcessCaenorhabditis elegansCentral Nervous System DiseasesCollaborationsComplementCrystallizationDetergentsDrug DesignElectrophysiology (science)FamilyGated Ion ChannelGenesGoalsHealthHomoHumanImmunoglobulin FragmentsInterventionInvertebratesIon ChannelIonsLigandsLinkMediatingMedicalMental HealthMental disordersMethodsModelingModificationMolecularMolecular ConformationNervous system structureNeurodegenerative DisordersNeuronsNicotinic ReceptorsOrganismOrthologous GeneParkinson DiseasePerfusionPeripheral Nervous SystemPhasePhysiologicalPositioning AttributePostdoctoral FellowPreparationProteinsPublic HealthReceptor ActivationReceptor GeneResearchResearch Project GrantsResolutionRestSchizophreniaSite-Directed MutagenesisStructureSynaptic TransmissionTechniquesTestingTherapeuticTrainingTransmembrane DomainWorkaddictionbaseblindcareerdesensitizationdesignexperienceglutamate-gated chloride channelinnovationinsightinterestmemberneurotransmissionnew therapeutic targetnovelpatch clampreceptorscreeningtherapeutic targetthree dimensional structure
项目摘要
Project Summary: Neuronal nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion
channels that mediate fast synaptic transmission and are important and novel therapeutic targets in
neurodegenerative diseases and mental illness. Currently there is no atomic-resolution structure for any
nicotinic receptor, and no receptor in this Cys-loop receptor superfamily has been structurally characterized in
more than one conformation. The long-term objectives of the research are to better understand the
conformational changes that underlie the transitions between different functional states and to develop reliable,
atomic-resolution models of nAChRs relevant to structure-guided drug design. Toward these goals the
following approach will be used. 1. Through receptor ortholog screening, identify an ¿7 receptor candidate for
crystallization, and test conditions to optimize receptor stability in detergent. 2. Using fast-perfusion patch
clamp and single channel analysis, test combinations of construct modifications and pharmacological probes to
stabilize distinct receptor conformations. 3. Crystallize receptor in different conformational states and
determine atomic-resolution structures of (a) a closed-resting receptor, (b) an open-activated receptor and (c) a
closed-desensitized receptor. The structural studies will be complemented with functional assays that test new
structure-based hypotheses regarding mechanisms of state transitions in the receptor. The results will have
broad implications for the Cys-loop receptor family in general and ¿7 nAChRs specifically.
项目摘要:神经型烟碱型乙酰胆碱受体(NAChRs)是五聚体配基门控离子
介导快速突触传递的通道,是糖尿病的重要和新的治疗靶点
神经退行性疾病和精神疾病。目前还没有原子分辨率结构用于任何
烟碱受体,以及这个Cys-loop受体超家族中的NO受体,其结构特征是
不止一种构象。这项研究的长期目标是更好地了解
构象变化是不同功能状态之间转换的基础,为了发展可靠的,
与结构导向药物设计相关的nAChRs的原子分辨模型。为了实现这些目标,
将采用以下方法。1.通过受体同源基因筛选,筛选出7个候选受体
结晶,以及优化洗涤剂中受体稳定性的测试条件。2.使用快速灌流补片
钳制和单通道分析,测试结构修饰和药理探针的组合
稳定不同的受体构象。3.结晶不同构象状态的受体和
测定(A)封闭休眠受体、(B)开放激活受体和(C)a的原子分辨结构
闭合脱敏受体。结构研究将得到功能分析的补充,测试新的
关于受体中状态转换机制的基于结构的假设。结果将会有
对一般的Cys-loop受体家族和特定的7个nAChRs的广泛影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ryan E Hibbs其他文献
Ryan E Hibbs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ryan E Hibbs', 18)}}的其他基金
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 24.64万 - 项目类别:
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
- 批准号:
10848770 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
- 批准号:
10322038 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
3D Structure and mechanism of the alpha7 nicotinic acetylcholine receptor
α7烟碱乙酰胆碱受体的3D结构和机制
- 批准号:
9233215 - 财政年份:2016
- 资助金额:
$ 24.64万 - 项目类别:
Structural studies of heteromeric nicotinic acetylcholine receptors
异聚烟碱乙酰胆碱受体的结构研究
- 批准号:
9155684 - 财政年份:2016
- 资助金额:
$ 24.64万 - 项目类别:
3D Structure and mechanism of the alpha7 nicotinic acetylcholine receptor
α7烟碱乙酰胆碱受体的3D结构和机制
- 批准号:
9896855 - 财政年份:2016
- 资助金额:
$ 24.64万 - 项目类别:
3D Structure and mechanism of the alpha7 nicotinic acetylcholine receptor
α7烟碱乙酰胆碱受体的3D结构和机制
- 批准号:
9079152 - 财政年份:2016
- 资助金额:
$ 24.64万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 24.64万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 24.64万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 24.64万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 24.64万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 24.64万 - 项目类别: